Thomas Layton Walton - 31 Dec 2021 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
10%+ Owner
Signature
/s/ Thomas Layton Walton
Issuer symbol
PHGE
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 15:24:48 UTC
Previous filing
09 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock, $0.0001 par value Other $0 -3,637,846 -100% $0.000000* 0 31 Dec 2021 By SymBiosis, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Warrants to purchase Common Stock Other $0 -1,875,000 -100% $0.000000* 0 31 Dec 2021 Common Stock 1,875,000 $5.00 By SymBiosis, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Thomas Layton Walton is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The common stock and warrants to purchase common stock previously reported by the reporting person are no longer indirectly beneficially owned by such reporting person and the reporting person specifically disclaims beneficial ownership of the securities reported. The shares are directly held by SymBiosis, LLC, over which the reporting person exercises investment discretion, but does not possess voting or dispositive power.